MiGo Tracker Program to Improve Home Exercise and Motor Recovery After Recent Stroke

What this Trial Is About

Researchers are evaluating the safety and effectiveness of the MiGo Tracker remote therapeutic monitoring RTM program for individuals who have experienced a subacute stroke. This randomized controlled trial includes 50 participants to compare the MiGo Tracker RTM program against usual care, which consists of prescribed home exercises without monitoring. The main goal is to see if the MiGo Tracker program leads to better motor recovery three months after stroke compared to usual care, potentially improving exercise adherence and health outcomes for stroke survivors. Participants will be randomly assigned to one of two groups. The intervention group will use the MiGo Tracker device during home exercise sessions, which logs exercise data uploaded to a dashboard. A study therapist will review exercise progress weekly via phone calls to help overcome any barriers. The control group will follow a home exercise program based on printed materials without monitoring. All participants will continue to receive usual post-stroke care, including outpatient rehabilitation. During the study, researchers will assess motor recovery using multiple tests, including the Upper Extremity Fugl-Meyer score at baseline and three months post-stroke. Other assessments include the Action Research Arm Test, Box and Blocks test, Motor Activity Log, Modified Ashworth Spasticity Scale, and Visual Analog Pain Scale. Participants will be monitored over the three-month period, with exercise adherence tracked for those using the MiGo Tracker. The study aims to provide detailed information on motor function improvement and exercise engagement after stroke.

MiGo Tracker Remote Monitoring of Home Exercise After Stroke